ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,813Medicare Part D Prescriptions Filled, Including Refills

Rank: 71 out of 229

$492K Total Retail Price of All Prescriptions

Rank: 51 out of 229

250 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 250 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 250 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 6,074 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 242 227 1 1
OMEPRAZOLE 214 199 2 4
METFORMIN HCL 172 144 3 6
LOSARTAN POTASSIUM 141 130 4 12
SPIRONOLACTONE 140 137 5 56
LISINOPRIL 135 117 6 2
SIMVASTATIN 114 95 7 3
AMLODIPINE BESYLATE 111 101 8 5
CARVEDILOL 104 102 9 31
POTASSIUM CHLORIDE 98 93 10 18
LOVASTATIN 96 91 11 11
HYDROCODONE-ACETAMINOPHEN 95 87 S3 12 7
LIOTHYRONINE SODIUM 93 87 13 152
HYDROCHLOROTHIAZIDE 89 80 14 9
FUROSEMIDE 88 88 15 8
NEXIUM 87 66 16 48
ALLOPURINOL 85 78 17 27
DIGOXIN 84 84 18 92
BYSTOLIC 81 77 19 141
TAMSULOSIN HCL 76 73 20 24
PAROXETINE HCL 72 72 21 49
DICLOFENAC SODIUM 69 51 22 168
SULINDAC 69 61 22 224
RAMIPRIL 68 62 24 167
METOPROLOL TARTRATE 68 60 24 13
METOPROLOL SUCCINATE 66 60 26 16
ENALAPRIL MALEATE 65 64 27 54
ESCITALOPRAM OXALATE 64 56 28 98
RANITIDINE HCL 62 58 29 32
SYNTHROID 61 49 30 46
ATORVASTATIN CALCIUM 61 59 30 15
MELOXICAM 60 60 32 45
CIPROFLOXACIN HCL 59 34 33 58
CELEBREX 59 37 33 71
BUMETANIDE 58 58 35 227
CRESTOR 58 54 35 30
TERAZOSIN HCL 57 57 37 74
ZOLPIDEM TARTRATE 56 53 38 20
DIOVAN 54 50 39 42
WARFARIN SODIUM 51 50 40 17
FLUTICASONE PROPIONATE 50 34 41 23
SINGULAIR 50 43 41 119
JANUVIA 50 39 41 59
DILTIAZEM 24HR ER 50 50 41 237
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.